Cellosaurus cell line PD-1.3 (CVCL

Cellosaurus PD-1.3 (CVCL_DF55)

Cross-references
Cell line name	PD-1.3
Synonyms	PD1.3; PD1.3.1; PD1 3.1
Accession	CVCL_DF55
Resource Identification Initiative	To cite this cell line use: PD-1.3 (RRID:CVCL_DF55)
Comments	Group: Patented cell line. Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4122. Monoclonal antibody isotype: IgG2b. Monoclonal antibody target: UniProtKB; Q15116; Human PDCD1/PD1/CD279.
Species of origin	Mus musculus (Mouse) (NCBI Taxonomy: 10090)
Hierarchy	Parent: CVCL_4032 (P3X63Ag8.653)
Category	Hybridoma
Publications	PubMed=20587542; DOI=10.1093/intimm/dxq049; PMCID=PMC3168865 Ghiotto M., Gauthier L., Serriari N.-E., Pastor S., Truneh A., Nunes J.A., Olive D. PD-L1 and PD-L2 differ in their molecular mechanisms of interaction with PD-1. Int. Immunol. 22:651-660(2010) PubMed=20693422; DOI=10.4049/jimmunol.0902487 Serriari N.-E., Gondois-Rey F., Guillaume Y., Remmerswaal E.B.M., Pastor S., Messal N., Truneh A., Hirsch I., van Lier R.A.W., Olive D. B and T lymphocyte attenuator is highly expressed on CMV-specific T cells during infection and regulates their function. J. Immunol. 185:3140-3148(2010) Patent=US9637546 Olive D., Serriari N.-E., Nunes J.A., Ghiotto M. PD-1 antibodies and PD-L1 antibodies and uses thereof. Patent number US9637546, 02-May-2017 Patent=US9896507 Olive D., Gondois-Rey F., Serriari N.-E., Pastor S. BTLA antibodies and uses thereof. Patent number US9896507, 20-Feb-2018 Patent=US10005839 Olive D., Pasero C., Gertner-Dardenne J. Antagonist of the BTLA/HVEM interaction for use in therapy. Patent number US10005839, 26-Jun-2018
Encyclopedic resources	Wikidata; Q54946766
Entry history
Entry creation	13-Jul-2016
Last entry update	21-Mar-2023
Version number	8